An interventional study of Face-to-face Virtual Reality Exposure Therapy and Internet-administered Virtual Reality Exposure Therapy in Social Phobia, Anxiety and Behavior Therapy, sponsored by Stockholm University. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-03-07.
Sponsored by Stockholm University · Not applicable, Interventional, and Treatment
Virtual Reality Exposure Therapy (VRET) is an efficacious treatment of fear and anxiety, but because of the high financial costs and technical complexity of the past generation of VR hardware, there has been no large-scale implementation of this promising treatment. The present study will investigate whether off-the-shelf, commercial VR hardware and software can be used as stimuli material to conduct in-session exposure therapy for speech anxiety. The study will recruit n=25+25 participants from the general public suffering from substantial speech anxiety, who will be randomized to either a waiting-list, or one-session VRET with a therapist, followed by four weeks of a progressive maintenance program encouraging in-vivo exposure. The waiting-list group will then receive an Internet-delivered VRET treatment program.
353 studies on the registry are indexed under Phobia, Social; 58 are open to participants now.
This study's enrollment of 50 is below the median of 77 across 325 interventional studies indexed under Phobia, Social.
Browse Phobia, Social studies →Stockholm University is the lead sponsor of 25 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
One-session Virtual Reality Exposure Therapy led by therapist (face-to-face), followed by a 4-week therapist-guided Internet-administered progressive maintenance program.
Behavioral: Face-to-face Virtual Reality Exposure Therapy
4-week waiting list, followed by therapist-guided, Internet-administered VRET with a 4-week progressive maintenance program.
Behavioral: Internet-administered Virtual Reality Exposure Therapy · Other: Waiting-list
In session, systematic, hierarchical exposure to feared stimuli with therapist.
Therapist-guided, Internet-administered Virtual Reality Exposure Therapy self-help program
Weekly assessments of public speaking
Public Speaking Anxiety Scale
Self-rating of public speaking anxiety
Time frame: Change from baseline: Week 0, 1, 2, 3, 4, 5 and 21
Liebowitz Social Anxiety Scale Self-Report
Self-rating of general social anxiety
Time frame: Change from baseline: Week 0, 5 and 21
Brief Fear of Negative Evaluation Scale
Self-rating of fear of negative evaluation
Time frame: Change from baseline: Week 0, 5 and 21
Patient Health Questionnaire 9-item
Self-rating of depressive symptoms
Time frame: Change from baseline: Week 0, 5 and 21
Generalized Anxiety Disorder 7-item
Self-rating of general anxiety symptoms
Time frame: Change from baseline: Week 0, 5 and 21
Brunnsviken Brief Quality of life scale
Self-rating of quality of life
Time frame: Change from baseline: Week 0, 5 and 21
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Jan 2017 to primary completion in May 2017, 4 months.
Of 140 non-industry interventional studies with no phase under Phobia, Social, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 44. This study's 4 months is below that.
Counting every sponsor, half of 145 studies reached it within 28 months; a quarter within 14 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stockholm University